GlassScriptPhysician profile
Jason T Palik
NPI 1407882129
$2,131.56
in general payments reported to CMS, 2019-2025
20 companies · $944 in 2025
The $944 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.67 · 2020: $52.72 · 2021: $83.08 · 2022: $229 · 2023: $76.25 · 2024: $663 · 2025: $944.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,683.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $369.05 | 2024-2025 | Xdemvy |
| Abbvie INC. | $323.52 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $293.05 | 2022-2025 | Vyzulta, Miebo, Infuse |
| Sun Pharmaceutical Industries INC. | $182.03 | 2019-2025 | |
| Amgen INC. | $139.77 | 2025 | Tepezza |
| Rxsight INC | $123.99 | 2024-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Dompe US, INC. | $120.21 | 2024-2025 | Oxervate |
| Oyster Point Pharma, INC. | $103.27 | 2022-2024 | Tyrvaya |
| Alcon Vision LLC | $102.09 | 2023-2025 | Rocklatan, Acrysof Iq Panoptix Uv Iol, Precision7 |
| Coopervision INC. | $58.90 | 2024-2025 | Myday Contact Lens |
| Novartis Pharmaceuticals Corporation | $54.29 | 2019-2021 | |
| Glaukos Corporation | $53.82 | 2025 | Idosetr |
| Johnson & Johnson Vision Care, INC. | $43.57 | 2022-2025 | |
| Kala Pharmaceuticals, INC. | $43.57 | 2019-2021 | |
| Allergan, INC. | $29.85 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $21.75 | 2025 | Iyuzeh |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Harrow Eye, LLC | $16.61 | 2025 | Vevye |
| Horizon Therapeutics Plc | $15.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Palik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.